said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity ...

said Wednesday it had achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger RNA (mRNA) Covid-19 vaccine. SK bioscience filed a nullity ...

May 14, 2025 Alnylam drops Covid vaccine patent case against Pfizer ... immunization campaign. Moderna says FDA has been constructive, but delays flu/COVID shot Moderna on Thursday pushed back ...

May 14, 2025 Alnylam drops Covid vaccine patent case against Pfizer ... to complete new clinical trial for delayed COVID-19 shot, WSJ reports Federal regulators have asked Novavax to complete ...

Seoul, April 23 SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with FDA that ...